New pill helps manage blood sugar in type 2 diabetes
NCT ID NCT04862923
First seen Nov 01, 2025 · Last updated Apr 25, 2026 · Updated 25 times
Summary
This study followed 336 adults with type 2 diabetes in the UK who were already prescribed Rybelsus (oral semaglutide). Researchers tracked changes in blood sugar levels and body weight over 8-10 months. The goal was to see how well the medication works in real-world settings, not in a controlled lab. Participants completed questionnaires during their regular doctor visits.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETES MELLITUS, TYPE 2 are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Master Centre for United Kingdom
Gatwick, West Sussex, RH6 0PA, United Kingdom
Conditions
Explore the condition pages connected to this study.